MeiraGTx Holdings MGTX Peer Comparison

NASDAQ MGTX
$13.78 -0.19 (-1.32%)
As of: Sep 4, 2026 · 2:22 PM EDT
Peer Comparison

172 Comparable Companies

Industry Gene and Cell Therapy

MeiraGTx Holdings plc (MGTX) is the 50th largest of 172 Gene and Cell Therapy companies by market capitalisation, at 1.26 Bn, behind Integra Lifesciences Holdings Corp at 1.27 Bn. It trades on a P/E of 7.64, 70% below the peer median of 25.52. The table below compares all 172 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 KRYS Krystal Biotech, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 10.54 Bn 43.66 23.93 9.70 Bn
2 CRSP CRISPR Therapeutics AG primary H-03 Pharmaceuticals and Biotechnology HG-01 5.39 Bn -11.13 402.14 5.39 Bn
3 LEGN Legend Biotech Corp primary H-03 Pharmaceuticals and Biotechnology HG-01 3.98 Bn -188.81 3.13 3.01 Bn
4 IOVA Iovance Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.91 Bn -18.70 12.03 3.61 Bn
5 BEAM Beam Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.11 Bn -36.43 19.94 3.11 Bn
6 QURE uniQure N.V. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.92 Bn -14.84 156.29 2.92 Bn
7 PGEN Precigen, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.55 Bn -7.57 29.75 2.55 Bn
8 SRPT Sarepta Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -17.10 1.19 1.55 Bn
9 MESO Mesoblast Ltd primary H-03 Pharmaceuticals and Biotechnology HG-01 2.24 Bn -38.60 18.46 2.14 Bn
10 TSHA Taysha Gene Therapies, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -13.73 374.43 2.05 Bn
11 VCEL Vericel Corp primary H-03 Pharmaceuticals and Biotechnology HG-01 2.04 Bn 81.36 6.66 1.88 Bn
12 NTLA Intellia Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -4.30 28.84 1.72 Bn
13 SLDB Solid Biosciences Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -7.28 — 1.49 Bn
14 MGTX MeiraGTx Holdings plc primary H-03 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 7.64 3.14 1.12 Bn
15 IMTX Immatics N.V. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.15 Bn -4.77 23.66 0.69 Bn
16 SANA Sana Biotechnology, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.15 Bn -5.35 — 1.15 Bn
17 FDMT 4D Molecular Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.05 Bn -5.86 11.42 0.69 Bn
18 CADL Candel Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -14.57 — 0.96 Bn
19 IMMX Immix Biopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.89 Bn -28.22 — 0.89 Bn
20 NGNE Neurogene Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.88 Bn -7.86 — 0.88 Bn
21 PRME Prime Medicine, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.66 Bn -3.49 161.21 0.66 Bn
22 ALLO Allogene Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.65 Bn -3.93 140.36 0.65 Bn
23 AUTL Autolus Therapeutics plc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -2.32 5.32 0.39 Bn
24 BNTC Benitec Biopharma Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -12.50 — 0.58 Bn
25 CAPR Capricor Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -4.32 — 0.55 Bn
26 CABA Cabaletta Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -2.85 — 0.52 Bn
27 KYTX Kyverna Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -3.31 — 0.50 Bn
28 RGNX REGENXBIO Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -2.67 2.50 0.37 Bn
29 OCGN Ocugen, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -5.57 99.46 0.36 Bn
30 ARTV Artiva Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.88 — 0.44 Bn
31 IRD Opus Genetics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.53 44.69 0.35 Bn
32 IPSC Century Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.00 — 0.18 Bn
33 RCKT Rocket Pharmaceuticals, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -25.02 — 0.43 Bn
34 LXEO Lexeo Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.85 — 0.42 Bn
35 PROK Prokidney Corp. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -2.87 468.68 0.38 Bn
36 ABEO Abeona Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -3.14 13.29 0.19 Bn
37 LYEL Lyell Immunopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -1.36 12,408.88 0.34 Bn
38 CLLS Cellectis S.A. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -9.83 5.53 0.16 Bn
39 FATE Fate Therapeutics Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -2.38 45.91 0.30 Bn
40 EDIT Editas Medicine, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.28 Bn — — 0.14 Bn
41 NWBO Northwest Biotherapeutics Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -7.18 128.49 0.28 Bn
42 LCTX Lineage Cell Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -11.91 20.88 0.22 Bn
43 RNAC Cartesian Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -2.50 183.55 0.27 Bn
44 TARA Protara Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -3.43 — 0.24 Bn
45 NKTX Nkarta, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.52 — 0.22 Bn
46 VYGR Voyager Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.55 6.09 0.09 Bn
47 DTIL Precision Biosciences Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -5.69 4.29 0.11 Bn
48 CRBU Caribou Biosciences, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -1.45 15.85 0.05 Bn
49 TNYA Tenaya Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.45 111.69 0.15 Bn
50 ATRA Atara Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -6.31 23.95 0.13 Bn
51 ZSQR Z Squared Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -7.69 53.02 0.13 Bn
52 HUMA Humacyte, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -1.18 66.50 0.14 Bn
53 ENGN enGene Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -1.00 — 0.13 Bn
54 ACET Adicet Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.05 — -0.01 Bn
55 ANIX Anixa Biosciences Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.94 — 0.10 Bn
56 INMB Inmune Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.12 — 0.04 Bn
57 INKT MiNK Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -5.02 — 0.06 Bn
58 APTN Adaptin Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -10.22 — 0.06 Bn
59 TCRX TScan Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.43 7.12 0.05 Bn
60 SGMOQ Sangamo Therapeutics, Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.37 1.14 0.02 Bn
61 CELU Celularity Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.48 1.65 0.04 Bn
62 MGX Metagenomi Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.47 2.02 0.04 Bn
63 ESLA Estrella Immunopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.79 — 0.03 Bn
64 TVGN Tevogen Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.21 — 0.03 Bn
65 MRKR Marker Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.29 — 0.01 Bn
66 INAB In8Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.28 — 0.02 Bn
67 LGVN Longeveron Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.90 17.97 0.01 Bn
68 GNTA Genenta Science S.p.A. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -3.83 — -0.01 Bn
69 PASG Passage BIO, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.39 — 0.02 Bn
70 PLUR Pluri Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.00 10.00 0.00 Bn
71 ADIA Adia Nutrition, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -75.51 69.62 0.01 Bn
72 FBLG FibroBiologics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.67 — 0.01 Bn
73 SNTI Senti Biosciences Holdings, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.16 607.51 0.01 Bn
74 GDTC CytoMed Therapeutics Ltd primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.36 41.92 0.01 Bn
75 ZEOX Zeo ScientifiX, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -2.21 1.34 0.01 Bn
76 LNAI Lunai Bioworks Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.05 86.15 0.00 Bn
77 TPST Tempest Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.28 — 0.00 Bn
78 PMCB PharmaCyte Biotech, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.18 — 0.00 Bn
79 MBIO Mustang Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.21 — 0.00 Bn
80 ISCO International Stem Cell CORP primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -9.66 0.32 0.00 Bn
81 CLDI Calidi Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.08 — 0.00 Bn
82 GNPX Genprex, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -0.01 Bn
83 CELZ Creative Medical Technology Holdings, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.21 515.15 0.00 Bn
84 RMTG Regenerative Medical Technology Group Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.11 0.12 0.00 Bn
85 BRTX BioRestorative Therapies, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.18 0.00 Bn
86 ERNAW Ernexa Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — 0.00 Bn
87 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 663.00 Bn 31.52 6.77 642.24 Bn
88 TMO Thermo Fisher Scientific Inc. secondary H-10 Medical Devices and Diagnostics HG-02 227.37 Bn 32.30 4.91 223.31 Bn
89 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.36 Bn -64.72 6.15 184.18 Bn
90 PFE Pfizer Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 162.45 Bn 37.19 2.55 150.75 Bn
91 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.87 Bn 31.52 11.03 131.01 Bn
92 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.49 Bn 61.05 2.45 38.83 Bn
93 ZTS Zoetis Inc. secondary H-05 Pharmaceuticals and Biotechnology HG-01 31.45 Bn 9.61 3.30 29.77 Bn
94 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.41 Bn -31.31 24.09 26.25 Bn
95 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.22 Bn -16.99 2,309.22 25.22 Bn
96 WST West Pharmaceutical Services Inc secondary H-07 Medical Devices and Diagnostics HG-02 24.18 Bn 44.01 7.27 23.75 Bn
97 IFF International Flavors & Fragrances Inc secondary M-02 Chemicals MG-01 22.03 Bn 75.46 2.21 21.47 Bn
98 STE STERIS plc secondary H-06 Medical Devices and Diagnostics HG-02 21.95 Bn 27.16 3.64 21.47 Bn
99 UTHR UNITED THERAPEUTICS Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 20.84 Bn 15.90 6.61 18.18 Bn
100 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.74 Bn -48.05 1.34 18.85 Bn
101 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.71 Bn 22.27 4.66 15.32 Bn
102 CRL Charles River Laboratories International, Inc. secondary H-11 Pharma Services HG-03 13.88 Bn -58.41 3.47 13.69 Bn
103 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.85 Bn 176.11 3.77 11.98 Bn
104 PODD Insulet Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.19 Bn 27.13 3.34 9.65 Bn
105 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.99 Bn 791.40 2.73 9.81 Bn
106 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.68 Bn -45.60 11.07 7.62 Bn
107 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.48 Bn -8.54 51.14 8.12 Bn
108 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn 18.05 9.97 7.29 Bn
109 ALKS Alkermes plc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 7.76 Bn 117.36 4.65 7.11 Bn
110 LNTH Lantheus Holdings, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 6.58 Bn 23.90 4.23 5.99 Bn
111 LQDA Liquidia Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.11 Bn 44.09 13.55 5.83 Bn
112 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.76 Bn 29.20 19.82 4.40 Bn
113 GRFS Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.33 Bn 20.99 0.32 4.17 Bn
114 TLX Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn — — 3.73 Bn
115 OGN Organon & Co. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.62 Bn 17.31 0.59 2.49 Bn
116 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.46 Bn -2.25 0.23 0.62 Bn
117 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.18 Bn 13.13 4.26 2.05 Bn
118 LKFT Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn 0.01 1.63 1.89 Bn
119 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -212.98 1,035.96 1.78 Bn
120 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -6.76 4.05 0.96 Bn
121 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -3.44 2.22 1.30 Bn
122 IART Integra Lifesciences Holdings Corp secondary H-06 Medical Devices and Diagnostics HG-02 1.27 Bn -175.76 0.77 1.00 Bn
123 MRVI Maravai Lifesciences Holdings, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 1.10 Bn -8.05 5.25 1.03 Bn
124 PCRX Pacira BioSciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.04 Bn 71.08 1.39 0.79 Bn
125 AMPH Amphastar Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 12.18 1.39 0.73 Bn
126 LXRX Lexicon Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -15.55 23.59 0.79 Bn
127 QDEL QuidelOrtho Corp secondary H-08 Medical Devices and Diagnostics HG-02 0.96 Bn — — 0.84 Bn
128 AVR Anteris Technologies Global Corp. secondary H-06 Medical Devices and Diagnostics HG-02 0.86 Bn -10.40 385.54 0.86 Bn
129 AQST Aquestive Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -8.65 12.51 0.68 Bn
130 EVO Evotec SE secondary H-11 Pharma Services HG-03 0.66 Bn — — 0.23 Bn
131 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.83 — 0.45 Bn
132 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -1.30 143.82 0.22 Bn
133 EMBC Embecta Corp. secondary H-06 Medical Devices and Diagnostics HG-02 0.34 Bn 3.93 0.34 0.13 Bn
134 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 3.74 2.59 0.34 Bn
135 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.93 3.71 0.17 Bn
136 EBS Emergent BioSolutions Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.82 0.42 0.18 Bn
137 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -17.16 1.65 0.16 Bn
138 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -3.15 19.90 0.10 Bn
139 OSUR Orasure Technologies Inc secondary H-08 Medical Devices and Diagnostics HG-02 0.26 Bn — 2,558.79 0.06 Bn
140 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.03 0.01 -10.82 Bn
141 UTMD Utah Medical Products Inc secondary H-06 Medical Devices and Diagnostics HG-02 0.23 Bn 22.95 6.27 0.14 Bn
142 HURA TuHURA Biosciences, Inc./NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.39 — 0.13 Bn
143 APYX Apyx Medical Corp secondary H-06 Medical Devices and Diagnostics HG-02 0.13 Bn -15.44 2.28 0.11 Bn
144 CDXS Codexis, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 0.13 Bn -4.28 1.69 0.08 Bn
145 GUTS Fractyl Health, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.11 Bn -0.87 — 0.11 Bn
146 PLYX Polaryx Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.65 — 0.08 Bn
147 PTHS Pelthos Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -0.78 1.61 0.06 Bn
148 FBIO Fortress Biotech, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 10.33 1.25 -0.11 Bn
149 NTRB NutriBand Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -2.43 40.33 0.07 Bn
150 XBIT XBiotech Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.63 — 0.07 Bn
151 HYFT MindWalk Holdings Corp. secondary H-11 Pharma Services HG-03 0.06 Bn -10.10 5.47 0.05 Bn
152 LASE Laser Photonics Corp secondary I-04 Machinery IG-02 0.06 Bn -1.51 8.92 0.05 Bn
153 SER Serina Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.50 326.44 0.02 Bn
154 SCLX Scilex Holding Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.20 -0.07 Bn
155 BHST Bioharvest Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.09 0.93 0.02 Bn
156 ATNM Actinium Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 2.87 0.93 0.03 Bn
157 NSYS Nortech Systems Inc secondary I-04 Machinery IG-02 0.03 Bn 12.07 0.37 0.03 Bn
158 ABVC Abvc Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -3.40 — 0.02 Bn
159 COSM Cosmos Health Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.81 0.22 0.01 Bn
160 CTXR Citius Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.33 2.16 0.02 Bn
161 NAII Natural Alternatives International Inc secondary H-12 Pharma Services HG-03 0.01 Bn -0.86 0.09 0.00 Bn
162 GELS Gelteq Ltd secondary H-12 Pharma Services HG-03 0.01 Bn — — 0.01 Bn
163 AIDX 20/20 Biolabs, Inc. secondary H-17 Healthcare Providers HG-04 0.01 Bn -0.99 2.94 0.00 Bn
164 DQWS DSwiss Inc secondary S-11 Household and Personal Products SG-05 0.01 Bn -27.32 4.18 0.01 Bn
165 CLGN CollPlant Biotechnologies Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.69 11.76 0.00 Bn
166 NXGL Nexgel, Inc. secondary H-12 Pharma Services HG-03 0.00 Bn -0.50 0.24 0.00 Bn
167 CASIF CASI Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
168 SKVI Skinvisible, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -2.25 116.18 0.00 Bn
169 GOVX GeoVax Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.11 2.59 0.00 Bn
170 BCAB BioAtla, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 0.24 0.00 Bn
171 RNAZ Transcode Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.04 — 0.00 Bn
172 GRMLW Greenland Mines Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 — -0.01 Bn